Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children

Completed 175 enrolled Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Nationwide Children's Hospital · collab

RandomizedTreatment

Summary

OBJECTIVES: Compare growth of lead-poisoned children receiving succimer (dimercaptosuccinic acid; DMSA) plus standard treatment to those receiving standard treatment only.

Timeline

Start: 1997-09
Primary completion: —
Completion: 1998-07

Publications

Background The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers. Paediatr Perinat Epidemiol. 1998 Jul;12(3):313-33. doi: 10.1046/j.1365-3016.1998.00122.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Succimer	Small molecule	—	Oral

Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children

Summary

Timeline

Publications

Drugs

Indications